{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Axonal Transport, Tau Protein, and Neurodegeneration in Alzheimer’s Disease",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "PUBCHEM": "^\\d+$",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/a5b84013a08880975ca84f40999e4404b14a97e2/external/go-names.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/cfd2ee89d1a71126da8b5f452544b7fe43be67e7/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/73688d6dc24e309fca59a1340dc9ee971e9f3baa/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hp-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"
    },
    "namespaces_uncached": [],
    "path": "pp2a/terwel2002.bel",
    "pybel_version": "0.13.3-dev"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Tau protein is a typical microtubule-associated protein (MAP) and thus is directly implicated in maintaining the integrity and stability of the micro- tubules and involved in axonal transport. On the other hand, recent findings propose a direct role for APP in axonal transport, as APP can link to kinesins moving along the microtubules (Kamal et al., 2001).",
      "key": "13503b8c084844dfbdaa423d0d8ef716ba94b8210538c12306450e4d7f91a0acfab769efcc95279c3a26ab3ac2be0d5f91e2ff230c1146bee629ad55059fe52b",
      "line": 85,
      "relation": "increases",
      "source": 31,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Tau protein is a typical microtubule-associated protein (MAP) and thus is directly implicated in maintaining the integrity and stability of the micro- tubules and involved in axonal transport. On the other hand, recent findings propose a direct role for APP in axonal transport, as APP can link to kinesins moving along the microtubules (Kamal et al., 2001).",
      "key": "dee40fc0bc10f93df7d48af977bdf9f2add95f94b207650d6f7745f76c240ab34d7b9c0604ed0a38fc7924cb0b8025c530684b2eff9f0059534c1bce1372d938",
      "line": 86,
      "relation": "association",
      "source": 31,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "The microtubule-binding properties of tau protein are believed to be important for a number of processes, e.g., the formation and maintenance of axons and for fast axonal transport (FAT).",
      "key": "fa62ef1e3fed2e5e7c152450f262a04ca95540e0674130d0b093dd1050f606aa6d0d69524d4453d86df5a1d789745a4ebe43b239c2ccc88a979bbb35fd16695d",
      "line": 106,
      "relation": "increases",
      "source": 31,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "An important function of tau protein involves the stabilization and spacing of microtubules, proba- bly by linking to a number of tubulin subunits, thereby preventing or slowing microtubule depoly- merization (Drubin and Kirschner, 1986). ",
      "key": "e00fc7610339de01ac2b259696359683e35ecb8ae482de1921a73d5a88956fbda6480a71a7a0bb9f4651d85952c19b98742dfa65e6b46c8efe64adc52d5f28f0",
      "line": 97,
      "relation": "decreases",
      "source": 31,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "The microtubule-binding properties of tau protein are believed to be important for a number of processes, e.g., the formation and maintenance of axons and for fast axonal transport (FAT).",
      "key": "1caff097da4398a62e71166b09b7ed1d0d320fee54f3aee7ed2045a6343a8173b964bb6e80ef7446e1afdbe8f0c051e0d9fa1806d0a8dbaaab74e562fc08a71b",
      "line": 105,
      "relation": "increases",
      "source": 31,
      "target": 6
    },
    {
      "key": "c4e71f1866eab20795e7e1d4b54fe09effb8b376e41712f8a130fe5192e07d83b0749cc2e2297b62cbea4bb7b1033909ea6d6423fa06166cb07543cee4249d48",
      "relation": "hasVariant",
      "source": 31,
      "target": 33
    },
    {
      "key": "9fbd9218812f1cd82827e2d73f3b6af04acbe1f408aaedcdc53c6fc17a36272c67cdcc254874f5473ba4443fa19971fe4877420e735c04f4f7353480d8e1f8b2",
      "relation": "hasVariant",
      "source": 31,
      "target": 32
    },
    {
      "key": "0efa2343a1aab409feeae95a44c4251f713383a6e606f151efb4055e8f77a89d772738244ac3792bc5938f0fe885967c3489d8612cccddfd37a4a5dd7ed7c968",
      "relation": "hasVariant",
      "source": 31,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Tau protein is a typical microtubule-associated protein (MAP) and thus is directly implicated in maintaining the integrity and stability of the micro- tubules and involved in axonal transport. On the other hand, recent findings propose a direct role for APP in axonal transport, as APP can link to kinesins moving along the microtubules (Kamal et al., 2001).",
      "key": "408ae27a1e3c090ec21adb07a62917bcf1698aa90db0e1a41b424bb6be6b3425e3e68775e3bf104596ceee35804f734c2b0f7fcccb3c7d2534d3761ad262be0a",
      "line": 86,
      "relation": "association",
      "source": 7,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Tau protein is a typical microtubule-associated protein (MAP) and thus is directly implicated in maintaining the integrity and stability of the micro- tubules and involved in axonal transport. On the other hand, recent findings propose a direct role for APP in axonal transport, as APP can link to kinesins moving along the microtubules (Kamal et al., 2001).",
      "key": "75f39f40981c99def99a8e6e43515061bb4d5240640274d52f30f083ae03f17aa2cd4e7370c3ec31e3c53c41573a3fe4107b1988b091a243c45a1641d026f192",
      "line": 87,
      "relation": "association",
      "source": 7,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "The following proposition has been recently reit- erated that axonal transport in AD could become disrupted by increased neuronal concentrations of tau protein",
      "key": "bab7ecf477cd1bdfa5bfe1ab61ab4a7210639ba1df401b9781158fe35903786e0a410cc050c75a57401b68e0da642d50e6e14300fef1b6c05613969ef9d5943d",
      "line": 208,
      "relation": "negativeCorrelation",
      "source": 7,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "The amount of Aβ produced could be altered by delayed axonal transport, as well as the precise species of metabolites of APPproduced— e.g., Aβ40 or 42, monomeric Aβ, or Aβ-oligomers or Aβ-derived diffusible ligands (ADDLs) (Lambert et al., 1998; Walsh et al., 2000).",
      "key": "77130b8e263ca807af0447961459c08e967dcef3f50f94865de1d410a447ee83c7dac0a3b2e0aeef49fc5efe2e9de208a9dc65522efecb0735522587c6b4a5c1",
      "line": 218,
      "relation": "association",
      "source": 7,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Although much further work is needed, these additional data demonstrate that GSK-3β is intimately involved in the architecture of axons and other neuronal processes, providing indirect support for its role in tau-mediated con- trol of axonal transport.",
      "key": "3aa10a778ac92e825b0af4dc63e67fb2bc5d3783b52477bd48d206534d88367bed89c5897980827a0927c8a5ae91357fcc98470efea88bfdbb4cadc833fde879",
      "line": 266,
      "relation": "association",
      "source": 7,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Tau protein is a typical microtubule-associated protein (MAP) and thus is directly implicated in maintaining the integrity and stability of the micro- tubules and involved in axonal transport. On the other hand, recent findings propose a direct role for APP in axonal transport, as APP can link to kinesins moving along the microtubules (Kamal et al., 2001).",
      "key": "ceb6509b2c3069e5ed3bccce6e17db8e890fa833846756b7be4d9e6aa3e477b19848d9c13d464c389704bdb13dc1f830fd138570ce3a0ef0774cc62174bf5c0d",
      "line": 87,
      "relation": "association",
      "source": 23,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "However, it is believed that the secreted form of APP plays important roles in neuronal plasticity and survival (Mattson, 1997).",
      "key": "2ea2b7c5bc8a854437aef5e2fba1148a120f77a355fc3bd625c5ddd175a05142f81b0a9ea4dbb62def07a30a821e80cb0e772c7e791f2b7fbff703019d3636e9",
      "line": 273,
      "relation": "association",
      "source": 23,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "However, it is believed that the secreted form of APP plays important roles in neuronal plasticity and survival (Mattson, 1997).",
      "key": "70ae6f49ccb6fc492bda72b8f107d0df1e721d232aaa9d328c6b9c1afae3f3794df14d9519916732223e58132bf9c8bc997d18edd782b7052ab19e413156c5f8",
      "line": 274,
      "relation": "association",
      "source": 23,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 10
    },
    {
      "key": "18e162c23492952c1f4fc6d6b77a1fe4e6f829a57bb1647107b473899192767fc9e77fba0b52808f2d8f10b546edac97d7e2d478ef0e11d87d0816dd78ee531c",
      "relation": "hasComponent",
      "source": 14,
      "target": 23
    },
    {
      "key": "0e696bb0e42df955b27a7d990cf4a14246ab0614f96a11c0a8cd54199f69a424f250c26ed00799410693521d363faeb96f8a7dfa07d29c516df66311f4f543db",
      "relation": "hasComponent",
      "source": 14,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " Among the specific “proline-dependent” kinases that can phosphorylate protein tau at dif- ferent sites in vitro, special attention is dedicated to glycogen-synthase kinase-3β (GSK-3β) (Michel et al., 1998), mitogen-activated protein kinase (MAPK) (Drewes et al., 1992), stress-activated protein kinases (SAPKs) (Goedert et al., 1997) and cyclin-dependent kinases (CDKs) including cdc2 and cdk5 (Baumann et al., 1993; Patrick et al., 1999).",
      "key": "69e3934509a07ace4e26276d74de48f774ddb95d9c14b2ec9174aeae3e9584fde20c75c9d28d6123e5d15a2a8add3b2912fc53acc0c56c892aef7a1b0b1a3835",
      "line": 120,
      "relation": "increases",
      "source": 28,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Spinal Cord": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Neuronally overexpressed GSK-3β was demonstrated to hyperphosphorylate tau protein in vivo in the brain and spinal cord of double- transgenic mice (Spittaels et al., 2000) thereby reducing the amount of protein tau associated with microtubules by 50% (Spittaels et al., 2000).",
      "key": "4a0ecfa71c8aa90870d12b7b000429997b4752a7ddf998f35746d94ac775ec2d88d485fdf2db5b488ce487a55e0cc056d89f3f1105e1cf89de493cebfb8dd509",
      "line": 230,
      "relation": "increases",
      "source": 28,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Spinal Cord": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Neuronally overexpressed GSK-3β was demonstrated to hyperphosphorylate tau protein in vivo in the brain and spinal cord of double- transgenic mice (Spittaels et al., 2000) thereby reducing the amount of protein tau associated with microtubules by 50% (Spittaels et al., 2000).",
      "key": "2865dbe543243f8c1d368d7cba00124d209b500ccbec1956439184ca9594f2c5a0d90bdee6327236f523c842ffb1a34581e52edd0f746c9a6b45e910b8d88ca1",
      "line": 231,
      "relation": "decreases",
      "source": 28,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Spinal Cord": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " More- over, the unbound tau protein was hyperphospho- rylated and especially at the AD-2 epitope, e.g., an epitope shown to contain serine 396 and serine 404.",
      "key": "c0815e67365f830153f1cade8eb11493aef8bb7580180028d6044e9dd16cb9f2cf6ab0e6d71e9261117f07ddd61e79e7123bc8c2b2d88e8f20d50d7459f2a1c1",
      "line": 243,
      "relation": "increases",
      "source": 28,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Surprisingly, the axonopathy was rescued in the tau x GSK-3β double-transgenic mice, together with a near-total normalization of the functional disabilities.",
      "key": "b02bc64f2e95980084432006ba1ad009680ffa6349bbcad40da490d6d440648886d3e54a834b0b4e33d460b5196da39934d89ef8d0c92382f99a342a25aa34bb",
      "line": 255,
      "relation": "increases",
      "source": 28,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Although much further work is needed, these additional data demonstrate that GSK-3β is intimately involved in the architecture of axons and other neuronal processes, providing indirect support for its role in tau-mediated con- trol of axonal transport.",
      "key": "819b76416e30ab0c5334ab7542861b0009e06ad2b13276d96008277a669f5272cdcf1268e6b946a1bfc369eabe3281cf72485ea7addf70e3b6b2b188329e33fb",
      "line": 266,
      "relation": "association",
      "source": 28,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " Among the specific “proline-dependent” kinases that can phosphorylate protein tau at dif- ferent sites in vitro, special attention is dedicated to glycogen-synthase kinase-3β (GSK-3β) (Michel et al., 1998), mitogen-activated protein kinase (MAPK) (Drewes et al., 1992), stress-activated protein kinases (SAPKs) (Goedert et al., 1997) and cyclin-dependent kinases (CDKs) including cdc2 and cdk5 (Baumann et al., 1993; Patrick et al., 1999).",
      "key": "f1abacfabe14e908730495eb48f09acf8208a41735d31e21d276205d47315f3d58ab2ea9ce1db8233a5a5b0fd01ac295bce310437348ec73080ebc6116074831",
      "line": 121,
      "relation": "increases",
      "source": 16,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " Among the specific “proline-dependent” kinases that can phosphorylate protein tau at dif- ferent sites in vitro, special attention is dedicated to glycogen-synthase kinase-3β (GSK-3β) (Michel et al., 1998), mitogen-activated protein kinase (MAPK) (Drewes et al., 1992), stress-activated protein kinases (SAPKs) (Goedert et al., 1997) and cyclin-dependent kinases (CDKs) including cdc2 and cdk5 (Baumann et al., 1993; Patrick et al., 1999).",
      "key": "61b4ff5af86055321a6920c1cb19c7169901714a971f3b76a0e180f011b78fb57784c7ae4ebca724c2489eae55e25c24ccddd685642608a8151b55fd1a8a919a",
      "line": 122,
      "relation": "increases",
      "source": 30,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " Among the specific “proline-dependent” kinases that can phosphorylate protein tau at dif- ferent sites in vitro, special attention is dedicated to glycogen-synthase kinase-3β (GSK-3β) (Michel et al., 1998), mitogen-activated protein kinase (MAPK) (Drewes et al., 1992), stress-activated protein kinases (SAPKs) (Goedert et al., 1997) and cyclin-dependent kinases (CDKs) including cdc2 and cdk5 (Baumann et al., 1993; Patrick et al., 1999).",
      "key": "2a4ce4a534ddef3ec32701fa6c1946bb266d1dc5dc0badf9031af9f6195b042f91445a5dbd77e8c8b792c70ce789d31a06c07c02b79a26019078b085a8676da3",
      "line": 123,
      "relation": "increases",
      "source": 26,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " Among the specific “proline-dependent” kinases that can phosphorylate protein tau at dif- ferent sites in vitro, special attention is dedicated to glycogen-synthase kinase-3β (GSK-3β) (Michel et al., 1998), mitogen-activated protein kinase (MAPK) (Drewes et al., 1992), stress-activated protein kinases (SAPKs) (Goedert et al., 1997) and cyclin-dependent kinases (CDKs) including cdc2 and cdk5 (Baumann et al., 1993; Patrick et al., 1999).",
      "key": "bfb226ffef2327774f06054104928849fb579e8ec00b4dd719276b73e17729ce637609619530bd003dc74dc58503396fb72590a269624e95ccb2c8d56d582b4e",
      "line": 124,
      "relation": "increases",
      "source": 27,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Other serine and threonine residues, not followed by proline, are phosphorylated by other protein kinases, including microtubule-affinity-regulating kinase (MARK) (Drewes et al., 1993), calcium/ calmodulin kinase II (CAMKII), cAMP-dependent kinase (PKA) (Johnson et al., 1992), and casein kinase II (Greenwood et al., 1994).",
      "key": "b011072efd2756c1b7cf7c81245795fb1bbebbe92b2092a47145eab24ba34763fe6a367dc8c40535b75f6ab9e8119f4499c8b1f0c715991c85cb20f60f5f9016",
      "line": 135,
      "relation": "increases",
      "source": 35,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Other serine and threonine residues, not followed by proline, are phosphorylated by other protein kinases, including microtubule-affinity-regulating kinase (MARK) (Drewes et al., 1993), calcium/ calmodulin kinase II (CAMKII), cAMP-dependent kinase (PKA) (Johnson et al., 1992), and casein kinase II (Greenwood et al., 1994).",
      "key": "5e6d6d4043c71a176181f13b903f24fd6a837b3e204c28ea7328d63470f767285dc5f682a7ee3a9e3d39395c5308ea94b63d9ce4490920a867d76c3f1a32360c",
      "line": 136,
      "relation": "increases",
      "source": 25,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Other serine and threonine residues, not followed by proline, are phosphorylated by other protein kinases, including microtubule-affinity-regulating kinase (MARK) (Drewes et al., 1993), calcium/ calmodulin kinase II (CAMKII), cAMP-dependent kinase (PKA) (Johnson et al., 1992), and casein kinase II (Greenwood et al., 1994).",
      "key": "78cf70468d140b2b9a8fffe0d9d039e7d01328c68db54dc585081c1428c4c2cd20742c80730bc792e647a9e0f20cb371b52e6224259ba364c368973882f1fb3d",
      "line": 137,
      "relation": "increases",
      "source": 17,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Other serine and threonine residues, not followed by proline, are phosphorylated by other protein kinases, including microtubule-affinity-regulating kinase (MARK) (Drewes et al., 1993), calcium/ calmodulin kinase II (CAMKII), cAMP-dependent kinase (PKA) (Johnson et al., 1992), and casein kinase II (Greenwood et al., 1994).",
      "key": "0aa372bb7be4451ddc8e6b123445ce67f8289d723862b322006bdc81b6277a5171b6b96474232776ea8e18e88550f97bfda85cd596bc09af26954615ef4bc194",
      "line": 138,
      "relation": "increases",
      "source": 15,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " Tau protein is rapidly dephosphorylated by endogenous phosphatases such as protein phosphatases 1, 2A, and 2B (cal- cineurin) that are all present in the brain, and effec- tively dephosphorylate tau protein in vitro. ",
      "key": "db2ad8a759836c34933fffac4b55aed2dad4a4e54986a7478de906cd18ee7c95cbde1ce7f2c6bd1e678816c6867d251e723c55f3dbb2ef13d7ad212a589cf351",
      "line": 148,
      "relation": "decreases",
      "source": 18,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " Tau protein is rapidly dephosphorylated by endogenous phosphatases such as protein phosphatases 1, 2A, and 2B (cal- cineurin) that are all present in the brain, and effec- tively dephosphorylate tau protein in vitro. ",
      "key": "37c3e3deae526a03a06702881ee57a0e4c4e27392bcbd41822f8dabd6e0e7b17ecdadfa4b380192b0065a1d05316f6a50243fa80d0e418645bc27f7d247586aa",
      "line": 149,
      "relation": "decreases",
      "source": 19,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " Tau protein is rapidly dephosphorylated by endogenous phosphatases such as protein phosphatases 1, 2A, and 2B (cal- cineurin) that are all present in the brain, and effec- tively dephosphorylate tau protein in vitro. ",
      "key": "db038cee51dbf704991ad3af31c247947fdf5a4488f88e21315c3e9ab94acf9fdda9ba62389a719f23946a26e33fa73f8494b87930c2564812cb6825765dac5a",
      "line": 150,
      "relation": "decreases",
      "source": 20,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " TSubsequently, Wallerian degeneration and severe muscle wasting and motoric problems demon- strated the extensive neurodegeneration caused by the overexpression of human tau protein in a gene- dosage fashion.",
      "key": "9746c50fce6859be11832d3606744af1477bcfb5c6e48c1f6d40cb4de6c6c5087fe5f54e8468897ff719846b2268071b14610f90cf9339b6eb1cfb6ea57a7973",
      "line": 162,
      "relation": "increases",
      "source": 22,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " TSubsequently, Wallerian degeneration and severe muscle wasting and motoric problems demon- strated the extensive neurodegeneration caused by the overexpression of human tau protein in a gene- dosage fashion.",
      "key": "9e5df1cc6bc4a29637ecf823051facf834e709b6d65e321737db6b6a4983ac3fedb32aa68c1be21b66a785c8542a6ba0ab13171fcb6c5b3e0ee901d87773d596",
      "line": 163,
      "relation": "increases",
      "source": 22,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " TSubsequently, Wallerian degeneration and severe muscle wasting and motoric problems demon- strated the extensive neurodegeneration caused by the overexpression of human tau protein in a gene- dosage fashion.",
      "key": "b8d3da53e13ec6717b659c0de099e64ee93868cea879cdbacc5df4f05291dfbf4559b85ce4bf3bce6f3bf5d7b5c1c86ddec4eb8f873e1e5b83c31cf7ac27f680",
      "line": 164,
      "relation": "increases",
      "source": 22,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Evidently, this argues for critical levels of protein tau-4R in the pathology of FTD and by exten- sion, in AD.",
      "key": "b381cfa8a7f3aaf07b3d34a177a5ba58857fbbcc3b653f146370dfc51d144287dcd48d0b2a96d1c32d06eca2229d3b7851475d7ce1919273f914f81af6fd0b64",
      "line": 199,
      "relation": "positiveCorrelation",
      "source": 22,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Evidently, this argues for critical levels of protein tau-4R in the pathology of FTD and by exten- sion, in AD.",
      "key": "eab172cf497a4579b2b9e2333cae36d1f632752ef83abb35c6e4abed1c6f1ed535ecba85831ee9b1e7e3f4b4a668661deed494f788eee5cc14c34ff63466ad7c",
      "line": 200,
      "relation": "positiveCorrelation",
      "source": 22,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": ". In ALS, accumulation of NFs is a prominent feature (Rouleau et al., 1996), and it has been demonstrated that NFs contribute heavily to the axonopathy of tau transgenic mice (Ishihara et al., 2001a).",
      "key": "c32094426c6597f8707627daf69760a9a585bb099b24a5f039355580cbc9a51f28d0c5486c95c7adad5fd514695e02e1147872d317c44019527f7fc84ffebb20",
      "line": 174,
      "relation": "positiveCorrelation",
      "source": 39,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": ". In ALS, accumulation of NFs is a prominent feature (Rouleau et al., 1996), and it has been demonstrated that NFs contribute heavily to the axonopathy of tau transgenic mice (Ishihara et al., 2001a).",
      "key": "1be6a6a0acbe65827111ddd11fcc0608e046cbcf8be18b936a28d6653f2792be8865aa91171b87c8f5c2f3a791869ec4ddbaaa43484dc2e2087cc7c698f31761",
      "line": 174,
      "relation": "positiveCorrelation",
      "source": 2,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": ". In ALS, accumulation of NFs is a prominent feature (Rouleau et al., 1996), and it has been demonstrated that NFs contribute heavily to the axonopathy of tau transgenic mice (Ishihara et al., 2001a).",
      "key": "7fb474f42e7dc7c4043fff82be75a32784f7b0925d616f8b10e6ca3d8c347c7e51d063b20b6421b5f9a0b91cbd7acd5fae9b61068834675ca909cf45be09d149",
      "line": 176,
      "relation": "negativeCorrelation",
      "source": 2,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": ". In ALS, accumulation of NFs is a prominent feature (Rouleau et al., 1996), and it has been demonstrated that NFs contribute heavily to the axonopathy of tau transgenic mice (Ishihara et al., 2001a).",
      "key": "3e9c07c77736c63ed381be4b47f51d37fb6245787b42e6437a7b8bbbd0ee8251a7ce95a4672d0292d31a67b448c37e9bea8bf2ef14871c7acc45265c7a90a348",
      "line": 176,
      "relation": "negativeCorrelation",
      "source": 3,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "For the sake of completeness, we also refer to tau- 3R transgenic mice that developed another type of pathology in the hippocampus, e.g., straight fila- ments formed in aged mice older than 18 mo (Ishi- hara, 2001b), which was proposed to be relevant for AD, given the age-dependence.",
      "key": "e67febdc63e3e7aeb19e2908c1f5a19b35cdda20b52c4aab7b60655cf5f481620ad7b8ad46d564f17819c8181a47ecc0aafedb60b993aeb25f27bd0f2393f683",
      "line": 189,
      "relation": "increases",
      "source": 21,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "For the sake of completeness, we also refer to tau- 3R transgenic mice that developed another type of pathology in the hippocampus, e.g., straight fila- ments formed in aged mice older than 18 mo (Ishi- hara, 2001b), which was proposed to be relevant for AD, given the age-dependence.",
      "key": "c0efa55c00de53586e53973eb15dbf8653fffa23fca3342db8080189b9e81ff936efd2f3241e9e21e0b1b24f656334fca06fa8417996584d316ab2778606243b",
      "line": 190,
      "relation": "association",
      "source": 1,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "For the sake of completeness, we also refer to tau- 3R transgenic mice that developed another type of pathology in the hippocampus, e.g., straight fila- ments formed in aged mice older than 18 mo (Ishi- hara, 2001b), which was proposed to be relevant for AD, given the age-dependence.",
      "key": "c0d874e46c22beff19660c29d2ef839d21e334a909812fedf21086a2f09a1e7cc3f821050a291dc765adaecd6fc1e4b83ca7e88faa9001ec1dfc3c418e1b30aa",
      "line": 190,
      "relation": "association",
      "source": 38,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Evidently, this argues for critical levels of protein tau-4R in the pathology of FTD and by exten- sion, in AD.",
      "key": "8d867b4d31a03c26f8babe72aa2811084f5918fe9929309e074c6068a6bae8d44daad3bc0baa116b5f7900d07d8518e94b9520e19bb12535cc6c00913d1fd9c0",
      "line": 200,
      "relation": "positiveCorrelation",
      "source": 38,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "The following proposition has been recently reit- erated that axonal transport in AD could become disrupted by increased neuronal concentrations of tau protein",
      "key": "1af79b9076c7e800874a181336bb676848021f3e4c5847ef14d559f0f35c5e5cbb029f7eabd0eda81d6ee53a5d5eac1e82be47b3424a5106bdf1b7617d866193",
      "line": 208,
      "relation": "negativeCorrelation",
      "source": 38,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Spinal Cord": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " More- over, the unbound tau protein was hyperphospho- rylated and especially at the AD-2 epitope, e.g., an epitope shown to contain serine 396 and serine 404.",
      "key": "fceaf299140c8332c495a2a505ae0a77582f39c1463ee958a19f34c31a4dbe0924b538945ea949cbf9ef565e538864d429ce03ecfb7374572026435409368858",
      "line": 244,
      "relation": "association",
      "source": 38,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Evidently, this argues for critical levels of protein tau-4R in the pathology of FTD and by exten- sion, in AD.",
      "key": "f148701f58d79da33f336bbfc4dbf1703ab704db0f6c28c77e8b37c919bbc9f4cc6e3e925db8ab55d245df2c2ab438d98850dea6aa358b0a2270b617937cf2c1",
      "line": 199,
      "relation": "positiveCorrelation",
      "source": 40,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "The amount of Aβ produced could be altered by delayed axonal transport, as well as the precise species of metabolites of APPproduced— e.g., Aβ40 or 42, monomeric Aβ, or Aβ-oligomers or Aβ-derived diffusible ligands (ADDLs) (Lambert et al., 1998; Walsh et al., 2000).",
      "key": "51284be7f29b551b822400e629dfdfb1df7cfa9d3c9047d5bd11d4811d3c61f7e693dc9a3361a5924609df87a9f88f8bf9712c555cf6b0acb9d5c69fd3fda824",
      "line": 218,
      "relation": "association",
      "source": 0,
      "target": 7
    },
    {
      "key": "4ce0ea41882541441210763700bca11ef3ea7b396f5aeb3e5391bd031b30763505f5cfdbbf8998dfab42b4c348b32963cf56ed6715509040da02bdf245608c85",
      "relation": "hasComponent",
      "source": 12,
      "target": 4
    },
    {
      "key": "452a7de9dff6ef4b4518a74ed95932c2d170aa93527116090942bf5e71b85fea7c4108a00227bf6f57338346b6c967ece647e3ae0d09859b6f89f908673c9f5c",
      "relation": "hasComponent",
      "source": 12,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Spinal Cord": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": " More- over, the unbound tau protein was hyperphospho- rylated and especially at the AD-2 epitope, e.g., an epitope shown to contain serine 396 and serine 404.",
      "key": "a7e0bbd7135c5c63f4c35d9e8409c06d3cf29ed052bcc96739216f8c93b55f02651eeb44c94d22f0cd08c52af4241d6f7338d01deb4a9c65d6887757a80dabfb",
      "line": 244,
      "relation": "association",
      "source": 34,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "However, it is believed that the secreted form of APP plays important roles in neuronal plasticity and survival (Mattson, 1997).",
      "key": "d73ea381f8abf285b49df62414ac9bf5bd0cecf92595e0ef9cb36638212573a8e53c0a70b391a63218ad8c5b3280cdc618dbf14e6c853ae2ee6fbf1e3031bcc8",
      "line": 273,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "association",
      "source": 11,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "However, it is believed that the secreted form of APP plays important roles in neuronal plasticity and survival (Mattson, 1997).",
      "key": "d2a7b4dfebd5fff4155a69a02f756d047df3c542a5f9bf6f30b6ee19ff458651bc5d8f3d8b1b99e823b9a2afcbbfa81e1226f935176477146c842513f12bca6f",
      "line": 274,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "association",
      "source": 10,
      "target": 23
    },
    {
      "key": "144c801bcd6a7798ee3503348a24eff7549e7f4a3c0ee001e91af7c88a835b8e6ae179bfa85bda92d934d6b9da4d1681c88963d20052e2eb8af93082f721f090",
      "relation": "hasComponent",
      "source": 13,
      "target": 23
    },
    {
      "key": "e63e80c893f82ea21c030f81cfbc08a9835b5cbf753af47640f06583ebb792e780ed56c99ae1cf081f5885c03fecdbb49e945079e9ba37e44d7a2da335a97496",
      "relation": "hasComponent",
      "source": 13,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Most recently, this role became even more puz- zling, since APP was implemented as a kinesin-1 receptor (Kamal et al., 2000; 2001). APP apparently binds to the light chain of kinesin-1, which itself is responsible for anterograde axonal transport and consists of two light chains (KLC) associated with two heavy chains (KIF5B).",
      "key": "9b676a880b410690bf112ec120fe9aa8bfa284c271049c5f34e0b7b3e4372faaa683008424e6c36c2ce15c622753d8607d6a95f3484492fade860c057a85975e",
      "line": 286,
      "relation": "increases",
      "source": 29,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Dewachter I",
          "Terwel D",
          "Van Leuven F"
        ],
        "date": "2002-01-01",
        "first": "Terwel D",
        "last": "Van Leuven F",
        "name": "Neuromolecular medicine",
        "pages": "151-65",
        "reference": "12428809",
        "title": "Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "2"
      },
      "evidence": "Deletion  of  the C-terminus of APP695 or APPL, including the kinesin-binding region, disrupted axonal transport of APP695 and APPL.",
      "key": "2e908f6542a904eb0c9237f98a284de6b1f1fb7ded0af44e7f3311e608074d6ae3c9942282e8bf451453659679bede0953eb9b4965af059eb59b55b6f823f37e",
      "line": 294,
      "relation": "increases",
      "source": 24,
      "target": 5
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "function": "Abundance",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2",
      "name": "amyloid-beta",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(HBP:\"straight filaments\")",
      "function": "Abundance",
      "id": "61a431aac4a86dc633a456eabe3307503a36c81da1d973533605d6d42e69bf3b12890f707954cd2421ea5d563bdc2ffc62380871bfa43d31cf763c875e87b35e",
      "name": "straight filaments",
      "namespace": "HBP"
    },
    {
      "bel": "a(MESH:\"Intermediate Filaments\")",
      "function": "Abundance",
      "id": "49bbbcb351851d5fa1476d94393890035c167d05513e4328efbfce197f41d5365eb68d647a86d079e463084514bbcaa3b41e12f430e5a5188ed0221f16f05864",
      "name": "Intermediate Filaments",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Axons)",
      "function": "Abundance",
      "id": "b9459adb8419b819171fa893fdd95e86a7d9cdbb11543e8943c7ec71529965bbe7910a1282a8ad0d70eb070e87ce7a58c09dc3de9c63ef260809af3bb5dc5ba9",
      "name": "Axons",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Microtubules)",
      "function": "Abundance",
      "id": "423b251fc00ca8300e6cffacc8328a41dc26c7935969fd1bbcffa31f767128c32deebfe0aa07def102c24e674932310fff1d766b7db765c8f47dfc23de220438",
      "name": "Microtubules",
      "namespace": "MESH"
    },
    {
      "bel": "bp(GO:\"anterograde axonal transport\")",
      "function": "BiologicalProcess",
      "id": "3e2a461cd655539ec9974778be985c658ff333fb9fa15a9f30d1c37ab22b3e9026879c53df6ea417eeb9f5e4378442b8d4a592cd24b9f15164cbf979e7988fcd",
      "name": "anterograde axonal transport",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"axon development\")",
      "function": "BiologicalProcess",
      "id": "3931dbbb87a5862094a0182512182c6e8074c4fdf95a3537061e7374828f63002e73f874d6b6ea95a673e38599f37a0358598928b018250d14396a049d13368f",
      "name": "axon development",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"axonal transport\")",
      "function": "BiologicalProcess",
      "id": "05b46e2a47c4835f765deb7eb33b970b7abbb53b690b7881e2beda6bc739337253a12aaafa51ebf63ed9f7ad7f09bcd7f5ce4fda7373ed3f4f0eadedaf2c14d0",
      "name": "axonal transport",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"microtubule cytoskeleton organization\")",
      "function": "BiologicalProcess",
      "id": "3356284f19d78563a899c463825eabbb708ac0e9e404ad1c6468f8306503271f3cfee4d6346219e0dd4a3e1e04fb6e843ccf983d32342615102427d0bdf2140b",
      "name": "microtubule cytoskeleton organization",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"microtubule depolymerization\")",
      "function": "BiologicalProcess",
      "id": "cbc62aa7f87ffe4350701ec23c8ddf1148abf26bacc57be664ea8437f6626d6e51e860b0f28c5ae7aadf04cd58501bdc8cc60156643ce38b9fbc927d1522a6d5",
      "name": "microtubule depolymerization",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"negative regulation of neuron apoptotic process\")",
      "function": "BiologicalProcess",
      "id": "604700df2a3b96e852dc81a0e30bef78a500ccbbd396d54d0a709dec73388b08067ee1b8adb73b9d69d8e8cd70d2494ab3b9c22a17780258208aa03ea26350e5",
      "name": "negative regulation of neuron apoptotic process",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"regulation of neuronal synaptic plasticity\")",
      "function": "BiologicalProcess",
      "id": "189c028e1f0d725e43b188d335f32c0e7aab8d8bc1aac27e7bdda205e7f8c43a0362f53c3ce5130f3ddb64cca5b0dbfce9d5f4d234a7725de5d9554541c2fa44",
      "name": "regulation of neuronal synaptic plasticity",
      "namespace": "GO"
    },
    {
      "bel": "complex(a(MESH:Microtubules), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "a948e1174474c6b4e70dc45349edc9e0a34aea2495eda658b2c247a9fda75ac36b7a6558a362efe3ae9091830df8a0e5c8b18a024142d767ab4322ae9d191cc8",
      "members": [
        {
          "bel": "a(MESH:Microtubules)",
          "function": "Abundance",
          "id": "423b251fc00ca8300e6cffacc8328a41dc26c7935969fd1bbcffa31f767128c32deebfe0aa07def102c24e674932310fff1d766b7db765c8f47dfc23de220438",
          "name": "Microtubules",
          "namespace": "MESH"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "function": "Protein",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
          "name": "MAPT",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:APP), p(HGNC:KLC1))",
      "function": "Complex",
      "id": "245fa892d1b014239487aa9b343fba843e893f455343b4ef7ab59c0a2d2430177c057e149b7802dbfd3cff63f68f98e6c481e43c8dd021b957f8d52e0e757f3e",
      "members": [
        {
          "bel": "p(HGNC:APP)",
          "function": "Protein",
          "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc",
          "name": "APP",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:KLC1)",
          "function": "Protein",
          "id": "3a1941213c9c71520d8ece5a64c05b23fbfca33093442b4915e8f3eb4f0523ccc18d7f8c449a65b177973996c6280600732ca5b0bcbe91bd4275a141eeba18a2",
          "name": "KLC1",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:APP), p(HGNCGENEFAMILY:Kinesins))",
      "function": "Complex",
      "id": "a236fbd3f2a063a6b6497ba28fca89eeba55fd3f0f0a1395c92703b164b21006867e424fc186970231ddf3f3ddd13016ea53b1bc7a9e9819630a28eb503f1ba7",
      "members": [
        {
          "bel": "p(HGNC:APP)",
          "function": "Protein",
          "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc",
          "name": "APP",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNCGENEFAMILY:Kinesins)",
          "function": "Protein",
          "id": "47795069f72a6df867b9005d2fa36f9dd7eaa577d608b81b36a4e2bd7c5624af630d4b03426d4ef3daf6dbf08b64ff174fc72b9d8db7bef07dd1589409aff2fd",
          "name": "Kinesins",
          "namespace": "HGNCGENEFAMILY"
        }
      ]
    },
    {
      "bel": "p(FPLX:CK2)",
      "function": "Protein",
      "id": "a291fc6a26ba96211a47c155dae813c80cd48240bb6b03442e30c47daa552db9d9f9127d7f92b850e6cbb5cf8fc195c60a1e252054815457196d5148ee2e7464",
      "name": "CK2",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:ERK)",
      "function": "Protein",
      "id": "d47253e059ce1284f4d182a53246f4d993b24c69ceb8bee74fb2a12d7d07c4a0ea65603dbb5d741283f27159ddf01ff72e2c045c05128734b83ba3ef067837b4",
      "name": "ERK",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:PKA)",
      "function": "Protein",
      "id": "a312e28f30d661eb58c0cc3c07cda6812a6290acaa1b8c513be7a895fe1b15f1feb278ee6095359cd3e44eb43cf1864de0fd70d89d3cbcc5b18361fd31276f17",
      "name": "PKA",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:PPP1)",
      "function": "Protein",
      "id": "988419e86b60ec5d3089171f7ee147a5508044bd5e1f8fea8bf4c0fa388359ecda28e3df00821a28c84199c166df2f863b5396accdf0835c02a484c1a5ddf3d3",
      "name": "PPP1",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:PPP2)",
      "function": "Protein",
      "id": "a9377307576389f08c186ac62c6f48293be2fe1495d38cb53c33f9185f3625cb580b310ee4f6d15c636acf1f460f4b54f0dc8c94808295084b9484f709c91fdd",
      "name": "PPP2",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:PPP3)",
      "function": "Protein",
      "id": "29288b04a9dfd793412bfa5b26e36982faa941a95bbaf64d4ac8d44e635fa5e343524f32f98c3d32d8b2d9209ef7f8c7a820e61057365fda98ba43ddcd2b5d52",
      "name": "PPP3",
      "namespace": "FPLX"
    },
    {
      "bel": "p(HBP:\"3R tau\")",
      "function": "Protein",
      "id": "69e10fce57b3686846f5b3dfc26c631268b84a8a38eb814c13670588e4a660bca26f90187cc38c09c2891f39b1e5b3658911e774ced090fb08173eb8866545dd",
      "name": "3R tau",
      "namespace": "HBP"
    },
    {
      "bel": "p(HBP:\"4R tau\")",
      "function": "Protein",
      "id": "fed662167fa10f270ea26bf05155229f1c1fa7c54b4a2c13d46424e97c1c0be3dd98a23ccf6ebd1605ef472e4f2a923463d37869dcbc28a4bc3c3bf2bf19e239",
      "name": "4R tau",
      "namespace": "HBP"
    },
    {
      "bel": "p(HGNC:APP)",
      "function": "Protein",
      "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc",
      "name": "APP",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:APPL)",
      "function": "Protein",
      "id": "e07bbd3345382c5a4508aec4cc61fc0de93ae1da74f48e905c2e56bbf0db0b1cf553b93dd5bd2b45c9818e4ba99b472ef90812f2af53de85f6b1066f99b2ce1a",
      "name": "APPL",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CAMK2B)",
      "function": "Protein",
      "id": "4c3bf6950e5c123022de139f876b9150f77558600158782b6145a33be7fa7b77527a16ae56ad97f780dc778afad4ef3f1f14005d283fa9aa29434790d6a95dc5",
      "name": "CAMK2B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CDK2)",
      "function": "Protein",
      "id": "ad499bcb9c7ca2de8e3d699b60d3c3c75a3bfe51df16325064b57ad8de3442312f8213f77477e093234bd399a0c81575fdc0d2f9878d8cc7eedb3cca921efe2e",
      "name": "CDK2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CDK5)",
      "function": "Protein",
      "id": "a85beb5b2b9417fabbbcc2135b9533cb0766b38688caf02242632843ae455bad332fb625d6e8296ff77b40e841485a56854fc14e300552425d596e8a8e70fd3f",
      "name": "CDK5",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:GSK3B)",
      "function": "Protein",
      "id": "ac819ecac7786e3ea9b6906b318167c6a94fbbf428aff46f85083b83c50b9604342d39c1c36ff49c2cb3a04e491913164c3e4e7889dedd513b6196d9b0560c7c",
      "name": "GSK3B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:KLC1)",
      "function": "Protein",
      "id": "3a1941213c9c71520d8ece5a64c05b23fbfca33093442b4915e8f3eb4f0523ccc18d7f8c449a65b177973996c6280600732ca5b0bcbe91bd4275a141eeba18a2",
      "name": "KLC1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPK9)",
      "function": "Protein",
      "id": "fee61e84e05a9dd587ca029ecd5f3061002b35c81841f8f6161be1e0aefca3c4cff1688ca8c271fca7d3d1b51e45c4c839abde1f1ecb776260046ad9f27f5c30",
      "name": "MAPK9",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "function": "Protein",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
      "name": "MAPT",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(HBP:hyperphosphorylation))",
      "function": "Protein",
      "id": "ede67fb639f29861d91976fefa16d8279b53ae13a659f35d70ed12e01bf3f339ffcf701fc54c7c4e908fee9902c02aac3e0022dcae5a7afa217ed2d4dba133b0",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "hyperphosphorylation",
            "namespace": "HBP"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "function": "Protein",
      "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 396), pmod(Ph, Ser, 404))",
      "function": "Protein",
      "id": "39bce9d17a0e3ef84038e06e52460d0a74f6adb7a3bffaba4858b8ada9ad6cc683cfaf93b6bb11e329e2818937b3cb05c7bb618018d5bf2b718fbfcadcd03af5",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        },
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 404
        }
      ]
    },
    {
      "bel": "p(HGNC:MARK1)",
      "function": "Protein",
      "id": "3b923d6973c25cbdfee62919800a0d68a70b6bc3f9665505c92f2e7c97df7d1db6363714dd203f8704bf8d1ed22d79db964d4cdcf19f7c7184fd20a7122d66bb",
      "name": "MARK1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNCGENEFAMILY:Kinesins)",
      "function": "Protein",
      "id": "47795069f72a6df867b9005d2fa36f9dd7eaa577d608b81b36a4e2bd7c5624af630d4b03426d4ef3daf6dbf08b64ff174fc72b9d8db7bef07dd1589409aff2fd",
      "name": "Kinesins",
      "namespace": "HGNCGENEFAMILY"
    },
    {
      "bel": "path(HP:Neurodegeneration)",
      "function": "Pathology",
      "id": "147561abc7f6701abebffd45f44916b712f900d63acea6c80bb945bee3908e728bbe60dd1b63ce6c6833ee03a88f0537ad03e5da7f67e71176d2f91aad08f8ac",
      "name": "Neurodegeneration",
      "namespace": "HP"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "function": "Pathology",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541",
      "name": "Alzheimer Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Amyotrophic Lateral Sclerosis\")",
      "function": "Pathology",
      "id": "5e56d7b5172af0ae281c2f920b132d7b2263ae5eff7b0f1c9a22347914d8c169c79314aa7738c7e68cf75fac198de894bff58cb9fd4a0cb95ab434310fa07daa",
      "name": "Amyotrophic Lateral Sclerosis",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Frontotemporal Dementia\")",
      "function": "Pathology",
      "id": "65b349369f9bedd1a6220b3923747475397a886cb45f96f65e9aad66d695cfd560911459bd006d087e0ee4cbf06d8829549b3e32854fe68093e2b5834049d726",
      "name": "Frontotemporal Dementia",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Muscular Atrophy\")",
      "function": "Pathology",
      "id": "0e82e6780e7c7d2f373fc88c6404fe55aa4d07657dddfd43b5ee2bbc648fcd162b6c7e03f3ef3c3fdb595a9df9c39f77ed962995d2e1fd8ecd2dfc562e2f5839",
      "name": "Muscular Atrophy",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Wallerian Degeneration\")",
      "function": "Pathology",
      "id": "2c429eb73aef6b081dee30d9044598994f8f11d674288aa97d56046499201daed1b16763dffba29d0cf2e097318d10758b8d8faad149007313e407ad1c4b6b46",
      "name": "Wallerian Degeneration",
      "namespace": "MESH"
    }
  ]
}